SLNO Quantitative Stock Analysis | Nasdaq
Below is Validea’s guru fundamental report for SOLENO THERAPEUTICS INC (SLNO). Of the 22 guru strategies we follow, SLNO rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth.
SOLENO THERAPEUTICS INC (SLNO) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or…
